Mithra Pharmaceuticals S A : announces placement of EUR 125 million convertible bonds due 2

• Placement of EUR 125 million senior unsecured convertible bonds due 17 December 2025 has been completed;
• The Bonds will bear a coupon of 4.250% per annum;
• The initial conversion price will be set at a 25.00% premium above the reference price, which will be equal to the volume weighted average price of an ordinary share of Mithra on Euronext Brussels from market open to the close of trading on 10 December 2020 and will be announced by press release after the close of trading on Euronext Brussels today.

Liege, Belgium, 10 December 2020 - 17:30 CET - With reference to the press release issued on 10 December 2020 at 08:00 CET, Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the 'Company' or 'Mithra'), a company dedicated to women's health, announces that the offering (the 'Offering') of EUR 125 million senior unsecured convertible bonds due 17 December 2025 (the 'Bonds') has been completed.